Skip to main content
. 2014 Feb 11;9(2):e88032. doi: 10.1371/journal.pone.0088032

Table 5. Survival differences stratified by low MVD and high MVD in patients with or without BRF2 overexpression.

BRF2 overexpression BRF2 nonoverexpression
5-year survival Low MVD High MVD p Low MVD High MVD p
Overall 36.84% 40.00% 0.816 82.14% 40.00% 0.003
Disease-free 35.00% 38.46% 0.795 78.57% 30.00% 0.001